Prepared Retirement Institute’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,013
Closed -$330K 90
2025
Q1
$330K Sell
13,013
-1,843
-12% -$48.2K 0.21% 54
2024
Q4
$394K Sell
14,856
-465
-3% -$12.6K 0.23% 47
2024
Q3
$443K Sell
15,321
-8
-0.1% -$233 0.27% 37
2024
Q2
$429K Sell
15,329
-643
-4% -$17.7K 0.28% 42
2024
Q1
$443K Buy
15,972
+128
+0.8% +$3.55K 0.33% 36
2023
Q4
$456K Buy
+15,844
New +$479K 0.34% 41

Other funds holding PFE

Prepared Retirement Institute's PFE Position: Q2 2025 in Review

Prepared Retirement Institute sold out of Pfizer (PFE) in Q2 2025, closing a stake of 13,013 shares — an estimated $330K sold.

Prepared Retirement Institute first reported a position in PFE in Q4 2023 and held it in 6 quarters. The position peaked at $456K in Q4 2023. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Prepared Retirement Institute reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Prepared Retirement Institute sold 13,013 Pfizer shares in Q2 2025, an estimated $330K.
  • Prepared Retirement Institute first reported a position in Pfizer in Q4 2023 and held it in 6 quarters.
  • Prepared Retirement Institute's Pfizer position peaked at $456K in Q4 2023.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Prepared Retirement Institute's 13F filing for Q2 2025, filed 17 Jul 2025.